Phase I – Bioequivalence

295 trials 18 recruiting

Filter these 295 trials by condition, country, sponsor and more.

Open in Search →

A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing ticagrelor 90 mg hard capsules (PG402 [Celon Pharma]) … Ended

2023-504116-14-00 Prevention of atherothrombotic events in adult patients 2023-10-17
A Single Dose, Fed state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (Iasis Pharma) vs. FU… Ended

2023-503887-18-00 healthy subjects 2023-10-02
Randomized, Open-label, Single-Dose, Two-treatment, Two-period, Cross-over, Pivotal Bioequivalence Study Comparing Amoxicilin/Clavulanic aci… Ended

2023-503233-22-00 Not applicable (submitted trial is a bioequivalence stu 2023-09-27
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of… Ended

2023-504760-42-00 Not applicable (submitted trial is a bioequivalence stu 2023-09-27
Control Of BioEquivalence with Xenical (COBEX): A Phase I, randomized, active-control study to evaluate EMP22 pharmacodynamics and EMP16 pha… Ended

2023-505671-74-00 Obesity 2023-09-22
Randomised, crossover bioequivalence clinical trial of montelukast 10 mg capsules vs montelukast 10 mg film-coated tablets, after a single o… Ended

2023-506937-30-00 Asthma 2023-09-20
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Ended

2023-507226-16-00 Healthy volunteers 2023-09-13
Comparative Bioavailability of Empagliflozin 25 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, … Ended

2023-506416-41-00 No medical condition 2023-09-11
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Ended

2023-506559-10-00 Healthy volunteers 2023-09-07
Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fasting Conditions Ended

2023-504258-36-00 No medical condition 2023-09-01
A randomised, open-label, reference-replicated crossover trial to investigate the bioequivalence of two formulations of Silexan 80 mg in hea… Ended

2023-503647-34-00 Healthy volunteers 2023-08-31
Bioequivalence study between two fluticasone propionate 500μg/salmeterol 50μg inhalation powders Ended

2023-504789-48-00 Healthy volunteers: regular treatment of bronchial ast 2023-08-23
Comparative Bioavailability of Midazolam 7.5 mg/1.5 mL Oromucosal Solution (Buccolam®) Versus 10 mg/2 mL Solution for Injection (Hypnovel®) … Ended

2023-504903-10-00 No medical condition. 2023-08-16
RANDOMISED, CROSSOVER BIOEQUIVALENCE CLINICAL TRIAL OF APIXABAN 5 MG CAPSULES VS APIXABAN 5 MG FILM-COATED TABLETS, AFTER A SINGLE ORAL DOSE… Ended

2023-506035-15-00 thrombosis 2023-08-16
A Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Stage III and Stage IV … Ended

2022-502620-49-00 Resected Melanoma Stage III or Stage IV 2023-08-01
Bioequivalence study between two fluticasone propionate 250μg/salmeterol 50μg inhalation powders Ended

2023-505198-34-00 Healthy volunteers.Regular treatment of bronchial asthm 2023-07-31
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib… Ended

2023-504052-99-00 Musculoskeletal and connective tissue disorders, Dysmen 2023-07-31
Bioequivalence clinical trial of two formulations of hydrochlorothiazide. Ended

2023-505692-72-00 Healthy volunteers 2023-07-18
Phase 1 Study of BMS-986416 with and without Nivolumab in Solid Tumors Ended

2022-501317-31-00 Solid tumor 2023-06-29
Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Nonpregnant Female Subjects. Ended

2023-504523-83-00 No medical condition 2023-06-29
Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Nonpregnant Female Subjects. Ended

2023-504527-40-00 No medical condition 2023-06-29
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Ended

2023-504987-40-00 Healthy volunteers 2023-06-26
Pharmacokinetic study of minocycline in patients with nontuberculous mycobacterial disease Ended

2024-517758-87-00 Nontuberculous mycobacterial disease 2023-06-22
Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril… Ended

2023-503822-38-00 Not applicable (submitted trial is a bioequivalence stu 2023-06-19